Finance

Lists
HURA:NASDAQ
TuHURA Biosciences Inc
2,10 $
+0,48%
(+0,0100) 1D
2,06 $
-1,80% (-0,038)
After hours
Closed: 18 սեպ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HURA...
Open
2,11 $
High
2,14 $
Low
2,07 $
Mkt. cap
133,83 մլն
Avg. vol.
241,17 հզր
Volume
174,75 հզր
52-wk high
3,41 $
52-wk low
0,41 $
EPS
-0,54 $
Beta
-0,02
Shares outstanding
63,73 մլն
No. of employees
22
Open
2,11 $
High
2,14 $
Low
2,07 $
Mkt. cap
133,83 մլն
Avg. vol.
241,17 հզր
Volume
174,75 հզր
52-wk high
3,41 $
52-wk low
0,41 $
EPS
-0,54 $
Beta
-0,02
Shares outstanding
63,73 մլն
No. of employees
22
News stories
From web sources and news partners
About TuHURA Biosciences Inc
CEO-
Employees22
Founded1995
HeadquartersՏամպա, Ֆլորիդա, Միացյալ Նահանգներ
Sector-
Websitetuhurabio.com
Analyst ratings
Based on 2 analysts giving stock ratings to HURA in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for HURA in the last 3 months.
Highest
Current 2,10 $
10,00 $ (+376,19%)
Average
9,00 $ (+328,57%)
Lowest
8,00 $ (+280,95%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
8,00 $
+281%
08/25/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
10,00 $
+376,2%
08/20/2026
Silvan Turkcan
Citizens JMP
Buy
Initiated
9,00 $
+328,6%
04/27/2026
Unknown Analyst
Citizens JMP
Buy
Initiated
9,00 $
+328,6%
04/27/2026
Michael King
Rodman & Renshaw
Buy
Initiated
7,00 $
+233,3%
04/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4,97 մլն
6,06 մլն
5,23 մլն
6,62 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,76 մլն
2,34 մլն
2,30 մլն
2,14 մլն
Operating expense
6,73 մլն
8,39 մլն
7,53 մլն
8,76 մլն
Total operating expenses
6,73 մլն
8,39 մլն
7,53 մլն
8,76 մլն
Operating income
-6,73 մլն
-8,39 մլն
-7,53 մլն
-8,76 մլն
Other non operating income
-46,72 հզր
185,02 հզր
-
-
EBT including unusual items
-7,10 մլն
-6,76 մլն
-7,54 մլն
-9,22 մլն
EBT excluding unusual items
-6,79 մլն
-8,82 մլն
-7,54 մլն
-9,22 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7,10 մլն
-6,76 մլն
-7,54 մլն
-9,22 մլն
Net profit margin
-
-
-
-
Earnings per share
-0,14
-0,16
-0,13
-
Interest and investment income
6,06 հզր
609,00
21,28 հզր
7,62 հզր
Interest expense
-16,53 հզր
-608,75 հզր
-27,97 հզր
-467,63 հզր
Net interest expenses
-10,47 հզր
-608,14 հզր
-6,70 հզր
-460,01 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-6,71 մլն
-8,37 մլն
-7,51 մլն
-8,74 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps